Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H McCabe

Showing results (181-190 of 259) with videos related to

Pageof 26
Sort By:
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 12, 2018
Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the LiteratureStephen J X Murphy, A Ross Naylor, Jean-Baptiste Ricco, et al.
Circulation|September 7, 2007
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trialBenjamin M Scirica, David A Morrow, Hanoch Hod, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 6, 2000
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapyJ A de Lemos, E M Antman, D A Morrow, et al.
Journal of the American College of Cardiology|June 30, 2007
Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trialRobert P Giugliano, Stephen D Wiviott, Peter H Stone, et al.
Frontiers in Neurology|February 15, 2019
Extracranial and Intracranial Vasculopathy With "Moyamoya Phenomenon" in Association With Alagille SyndromeSiobhan Delaney, Ged O'Connor, William Reardon, et al.
Thrombosis and Haemostasis|June 30, 2011
Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44Andrew L Frelinger, Alan D Michelson, Stephen D Wiviott, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|February 19, 2022
Platelet Biomarkers in Patients with Atherosclerotic Extracranial Carotid Artery Stenosis: A Systematic ReviewArun Subramanian, Siobhan Delaney, Stephen J X Murphy, et al.
Circulation|February 6, 2004
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trialMarc S Sabatine, David A Morrow, Robert P Giugliano, et al.
Lancet (London, England)|April 2, 2008
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trialStephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, et al.
The American Journal of Cardiology|August 29, 2003
Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarctionC Michael Gibson, William J Gibson, Sabina A Murphy, et al.
Pageof 26

Showing results (181-190 of 259) with videos related to

Sort By:
Pageof 26
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 12, 2018
Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the LiteratureStephen J X Murphy, A Ross Naylor, Jean-Baptiste Ricco, et al.
Circulation|September 7, 2007
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trialBenjamin M Scirica, David A Morrow, Hanoch Hod, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 6, 2000
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapyJ A de Lemos, E M Antman, D A Morrow, et al.
Journal of the American College of Cardiology|June 30, 2007
Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trialRobert P Giugliano, Stephen D Wiviott, Peter H Stone, et al.
Frontiers in Neurology|February 15, 2019
Extracranial and Intracranial Vasculopathy With "Moyamoya Phenomenon" in Association With Alagille SyndromeSiobhan Delaney, Ged O'Connor, William Reardon, et al.
Thrombosis and Haemostasis|June 30, 2011
Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44Andrew L Frelinger, Alan D Michelson, Stephen D Wiviott, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|February 19, 2022
Platelet Biomarkers in Patients with Atherosclerotic Extracranial Carotid Artery Stenosis: A Systematic ReviewArun Subramanian, Siobhan Delaney, Stephen J X Murphy, et al.
Circulation|February 6, 2004
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trialMarc S Sabatine, David A Morrow, Robert P Giugliano, et al.
Lancet (London, England)|April 2, 2008
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trialStephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, et al.
The American Journal of Cardiology|August 29, 2003
Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarctionC Michael Gibson, William J Gibson, Sabina A Murphy, et al.
Pageof 26